ATM mutations alone do not predict early treatment need in chronic lymphocytic leukemia, study finds
In chronic lymphocytic leukemia (CLL), certain recurrent genetic alterations are known to influence disease progression and survival. One important abnormality is the loss of part of chromosome 11, ...
Low dose involved field radiation (IFRT) or no further treatment following complete response to initial chemotherapy in young adult (YA) patients 16–21 years of age with Hodgkin’s disease (HD): The ...
A family history of breast, prostate, and pancreatic cancers is linked to ATM and KRAS gene mutations, despite negative BRCA1/2 results. Genetic testing and counseling are crucial for understanding ...
A novel discovery in the field of pancreatic cancer treatment has been unveiled, revealing the epigenetic silencing of BEND4 as a potential synthetic lethal marker for enhancing the efficacy of ATM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results